-
A
Immunohistochemistry of cleaved caspase 3 (CC3) shows that the number of CC3+ cells (marked by black arrowheads) is increased in P5 Bcl6
F/F
;Nex
Cre
compared with control neocortex. Insets are enlargements of the boxed areas in corresponding panels.
-
B
Relative Bcl6 mRNA expression level determined by quantitative real‐time PCR using primers targeting a region of exon 8 is decreased in P0 Bcl6
F/F
;Nex
Cre
compared with control brains (n = 4). Results are expressed as mean ± s.e.m.; Student's t‐test; ***P < 0.001.
-
C
Quantification of the experiment shown in (A) (n = 3). Results are expressed as mean ± s.e.m.; Student's t‐test; *P < 0.05.
-
D
Quantification of neocortical area in P5 Bcl6
F/F
;Nex
Cre
and control brains (n = 3). Results are expressed as mean ± s.e.m.; Student's t‐test; **P < 0.01.
-
E
Heat map showing differentially expressed genes in laser‐microdissected superficial cortical layers of P5 Bcl6
F/F
;Nex
Cre
compared with control brains (n = 4).
-
F
Relative Foxo1 mRNA expression level determined by quantitative real‐time PCR is increased in laser‐microdissected superficial cortical layers of P5 Bcl6
F/F
;Nex
Cre
compared with control brains (n = 4). Results are expressed as mean ± s.e.m.; Student's t‐test; **P < 0.01.
-
G
RNA in situ hybridization showing upregulation of Foxo1 expression in P5 Bcl6
F/F
;Nex
Cre
compared with control neocortex.
-
H
Schematic representation of the experimental approach. Embryos are electroporated at E15.5 and sacrificed at P5.
-
I
DNA plasmids used in the experiment shown in (J and K).
-
J
Immunohistochemistry of electroporated P5 Bcl11a
F/F
neurons in superficial cortical layers with GFP (green) and cleaved caspase 3 (CC3, magenta) antibodies. Electroporation of CAG‐Cre
GFP
plasmid together with Foxo1‐shRNA
GFP
#4 into Bcl11a
F/F
neocortex reduces the number of CC3+ cells to control levels. White and black arrowheads indicate GFP+ CC3+ and GFP+ cells, respectively.
-
K
Quantification of the experiment shown in (J) (n = 4, CAG‐Ctl
GFP
/Ctl‐shRNA
GFP
; n = 3, CAG‐Cre
GFP
/Ctl‐shRNA
GFP
; n = 5, CAG‐Cre
GFP
/Foxo1‐shRNA
GFP
#4). Results are expressed as mean ± s.e.m.; one‐way ANOVA followed by Tukey's post‐hoc test; *P < 0.05.